Senior insider sale
AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$2.78M
100K shares
What this filing means
MILNE GEORGE M JR plans to sell 100K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $2.78M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/5/2026ACC: 0001950047-26-010033
Director
Since Jan 2022
100K
Shares to sell
$2.78M
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Previously Exercised Options
Cash
12/11/2019
13.24KPrivate Acquisition from Issuer or an Affiliate
N/A
8/8/2016
86.76KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2019 | Previously Exercised Options Cash | 13.24K | — |
8/8/2016 | Private Acquisition from Issuer or an Affiliate N/A | 86.76K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
100K
Market value
$2.78M
10/5/2026
Total
Units
100K
Value
$2.78M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/5/2026 | 100K | $2.78M | NASDAQ | Planned |
| Total | 100K | $2.78M | ||